Around 14,000 women in England may soon be able to access a new treatment for osteoporosis after NICE backed routine NHS use of Theramex's Eladynos. The health technology assessment (HTA) agency said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback